Last updated: April 17, 2009
Sponsor: The University of Texas Health Science Center, Houston
Overall Status: Completed
Phase
4
Condition
Colic
Stomach Discomfort
Lactose Intolerance
Treatment
N/AClinical Study ID
NCT00292344
TRA-04-01
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Inclusion criteria include: IRB approval; signing of a consent form;18 years of age orolder, providing of an unformed pre-treatment stool; females must be non-pregnant andnot nursing.
Exclusion
Exclusion Criteria:
- Exclusion criteria include: diarrhea longer than 72 hours; moderate or severedehydration, pregnancy or breast feeding, receipt of trimethoprim-sulfamethoxazole,azalide, doxycycline, or a fluoroquinolone in the past week; unstable medicalcondition; hypersensitivity to rifaximin or rifampin; fever (>100.6o F) or bloodydiarrhea.
Study Design
Total Participants: 316
Study Start date:
June 01, 2004
Estimated Completion Date:
August 31, 2005
Study Description
Connect with a study center
Universidad Autonoma de Guadalajara
Guadalajara, Jalisco
MexicoSite Not Available
University of Arizona, Colegio Guadalajara
Guadalajara, Jalisco
MexicoSite Not Available
University of San Diego at Iteso
Guadalajara, Jalisco
MexicoSite Not Available
Clinica Londres Morelos
Cuernavaca, Morelos
MexicoSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.